A Study of Ad26.COV2.S in Healthy Adults (COVID-19)
NCT04894305
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
380
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
Ad26.COV2.S
Sponsor
Janssen Vaccines & Prevention B.V.